P55 | MANAGEMENT OF NEUROLOGICAL TOXICITIES OF PATIENTS TREATED WITH IMMUNOTHERAPIES FOR MULTIPLE MYELOMA: A SINGLE-CENTER REAL WORLD EXPERIENCE

T cell redirecting therapies (TCRt) have dramatically improved the prognosis of relapsed/refractory multiple myeloma (RRMM) patients (pts), but they are also burdened by novel toxicities, among which neurological ones such as immune cell associated neurotoxicity syndrome (ICANS), headache, and neur...

Descripción completa

Detalles Bibliográficos

Autores principales:	E. Manzato, M. Puppi, M. Talarico, M. Iezza, S. Masci, S. Ghibellini, A. Vitale, S. Barbato, P. Tacchetti, L. Pantani, K. Mancuso, E. Zamagni
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Ferrata Storti Foundation 2026-04-01
Colección:	Haematologica
Acceso en línea:	https://haematologica.org/article/view/14068
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!